Global Cancer Supportive Care Drugs Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18749850

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18749850

Global Cancer Supportive Care Drugs Databank Market Report

The Cancer Supportive Care Drugs market was valued at $13,359.6 Million in 2020, and is projected to reach $24,003.1 Million by 2029 growing at a CAGR of 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of 7.21%. Bisphosphonates and Opioids segments collectively expected to account for about 50.0% share of the Cancer Supportive Care Drugs market in 2020, with the former constituting around 25.9% share. Bisphosphonates and ESAs (Erythropoiesis Stimulating Agents) segments are expected to witness significant growth rates at a CAGR of 7.21% and 7.15% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.7% in the overall Cancer Supportive Care Drugs market in 2020, and is anticipated to reach 40.1% by 2029.

1. Global Cancer Supportive Care Drugs Market, By Therapeutic Class: 1.1. Overview; 1.2. Anti-emetics; 1.2.1 Anti-emetics Market, By Region; 1.2.1.1 North America Anti-emetics Market, By Country; 1.2.1.2 Europe Anti-emetics Market, By Country; 1.2.1.3 Asia-Pacific Anti-emetics Market, By Country; 1.2.1.4 Rest of World Anti-emetics Market, By Country; 1.3. G-CSFs (Granulocyte-colony Stimulating Factors); 1.3.1 G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Region; 1.3.1.1 North America G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country; 1.3.1.2 Europe G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country; 1.3.1.3 Asia-Pacific G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country; 1.3.1.4 Rest of World G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country; 1.4. Bisphosphonates; 1.4.1 Bisphosphonates Market, By Region; 1.4.1.1 North America Bisphosphonates Market, By Country; 1.4.1.2 Europe Bisphosphonates Market, By Country; 1.4.1.3 Asia-Pacific Bisphosphonates Market, By Country; 1.4.1.4 Rest of World Bisphosphonates Market, By Country; 1.5. ESAs (Erythropoiesis Stimulating Agents); 1.5.1 ESAs (Erythropoiesis Stimulating Agents) Market, By Region; 1.5.1.1 North America ESAs (Erythropoiesis Stimulating Agents) Market, By Country; 1.5.1.2 Europe ESAs (Erythropoiesis Stimulating Agents) Market, By Country; 1.5.1.3 Asia-Pacific ESAs (Erythropoiesis Stimulating Agents) Market, By Country; 1.5.1.4 Rest of World ESAs (Erythropoiesis Stimulating Agents) Market, By Country; 1.6. Opioids; 1.6.1 Opioids Market, By Region; 1.6.1.1 North America Opioids Market, By Country; 1.6.1.2 Europe Opioids Market, By Country; 1.6.1.3 Asia-Pacific Opioids Market, By Country; 1.6.1.4 Rest of World Opioids Market, By Country; 1.7. NSAIDs and others; 1.7.1 NSAIDs and others Market, By Region; 1.7.1.1 North America NSAIDs and others Market, By Country; 1.7.1.2 Europe NSAIDs and others Market, By Country; 1.7.1.3 Asia-Pacific NSAIDs and others Market, By Country; 1.7.1.4 Rest of World NSAIDs and others Market, By Country
2. Global Cancer Supportive Care Drugs Market, By Region: 2.1. Overview; 2.2. North America; 2.2.1 North America Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.2.2 North America Cancer Supportive Care Drugs Market, By Country; 2.2.2.1 U.S.; 2.2.2.1.1 U.S. Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.2.2.2 Canada; 2.2.2.2.1 Canada Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.2.2.3 Mexico; 2.2.2.3.1 Mexico Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3. Europe; 2.3.1 Europe Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2 Europe Cancer Supportive Care Drugs Market, By Country; 2.3.2.1 Germany; 2.3.2.1.1 Germany Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2.2 France; 2.3.2.2.1 France Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2.3 U.K.; 2.3.2.3.1 U.K. Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2.4 Italy; 2.3.2.4.1 Italy Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2.5 Spain; 2.3.2.5.1 Spain Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.3.2.6 Rest of Europe; 2.3.2.6.1 Rest of Europe Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4. Asia-Pacific; 2.4.1 Asia-Pacific Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2 Asia-Pacific Cancer Supportive Care Drugs Market, By Country; 2.4.2.1 China; 2.4.2.1.1 China Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2.2 India; 2.4.2.2.1 India Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2.3 Japan; 2.4.2.3.1 Japan Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2.4 Australia; 2.4.2.4.1 Australia Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2.5 South Korea; 2.4.2.5.1 South Korea Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.4.2.6 Rest of Asia; 2.4.2.6.1 Rest of Asia Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.5. Rest of World; 2.5.1 Rest of World Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.5.2 Rest of World Cancer Supportive Care Drugs Market, By Country; 2.5.2.1 Brazil; 2.5.2.1.1 Brazil Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.5.2.2 South Africa; 2.5.2.2.1 South Africa Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.5.2.3 GCC; 2.5.2.3.1 GCC Cancer Supportive Care Drugs Market, By Therapeutic Class; 2.5.2.4 RoW Countries; 2.5.2.4.1 RoW Countries Cancer Supportive Care Drugs Market, By Therapeutic Class; RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD LIST OF TABLES; TABLE 1. Global Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 2. Anti-emetics Market Value, By Region, 2020-2029, Million USD; TABLE 3. North America Anti-emetics Market Value, By Country, 2020-2029, Million USD; TABLE 4. Europe Anti-emetics Market Value, By Country, 2020-2029, Million USD; TABLE 5. Asia-Pacific Anti-emetics Market Value, By Country, 2020-2029, Million USD; TABLE 6. Rest of World Anti-emetics Market Value, By Country, 2020-2029, Million USD; TABLE 7. G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Region, 2020-2029, Million USD; TABLE 8. North America G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD; TABLE 9. Europe G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD; TABLE 10. Asia-Pacific G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD; TABLE 11. Rest of World G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD; TABLE 12. Bisphosphonates Market Value, By Region, 2020-2029, Million USD; TABLE 13. North America Bisphosphonates Market Value, By Country, 2020-2029, Million USD; TABLE 14. Europe Bisphosphonates Market Value, By Country, 2020-2029, Million USD; TABLE 15. Asia-Pacific Bisphosphonates Market Value, By Country, 2020-2029, Million USD; TABLE 16. Rest of World Bisphosphonates Market Value, By Country, 2020-2029, Million USD; TABLE 17. ESAs (Erythropoiesis Stimulating Agents) Market Value, By Region, 2020-2029, Million USD; TABLE 18. North America ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD; TABLE 19. Europe ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD; TABLE 20. Asia-Pacific ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD; TABLE 21. Rest of World ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD; TABLE 22. Opioids Market Value, By Region, 2020-2029, Million USD; TABLE 23. North America Opioids Market Value, By Country, 2020-2029, Million USD; TABLE 24. Europe Opioids Market Value, By Country, 2020-2029, Million USD; TABLE 25. Asia-Pacific Opioids Market Value, By Country, 2020-2029, Million USD; TABLE 26. Rest of World Opioids Market Value, By Country, 2020-2029, Million USD; TABLE 27. NSAIDs and others Market Value, By Region, 2020-2029, Million USD; TABLE 28. North America NSAIDs and others Market Value, By Country, 2020-2029, Million USD; TABLE 29. Europe NSAIDs and others Market Value, By Country, 2020-2029, Million USD; TABLE 30. Asia-Pacific NSAIDs and others Market Value, By Country, 2020-2029, Million USD; TABLE 31. Rest of World NSAIDs and others Market Value, By Country, 2020-2029, Million USD; TABLE 32. Global Cancer Supportive Care Drugs Market Value, By Region, 2020-2029, Million USD; TABLE 33. North America Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 34. North America Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 35. U.S. Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 36. Canada Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 37. Mexico Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 38. Europe Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 39. Europe Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 40. Germany Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 41. France Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 42. U.K. Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 43. Italy Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 44. Spain Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 45. Rest of Europe Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 46. Asia-Pacific Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 47. Asia-Pacific Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 48. China Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 49. India Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 50. Japan Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 51. Australia Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 52. South Korea Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 53. Rest of Asia Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 54. Rest of World Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 55. Rest of World Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD; TABLE 56. Brazil Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 57. South Africa Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 58. GCC Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; TABLE 59. RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD; RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD